Cancer pain
Conditions
Interventions
Experimental group:epidural infusion system
Control group:Intravenous analgesic system
Sponsors
Foshan Chancheng central hospital
Eligibility
Sex/Gender
All
Age
35 Years to 75 Years
Inclusion criteria
Inclusion criteria: We selected 72 patients with upper abdominal cancer pain who were treated in our hospital from August 2015 to August 2018, aged 35 to 75 years, and had a body mass index of 18 to 30 kg/m2. Inclusion criteria: (1) After clinical diagnosis, patients were diagnosed with upper abdominal pain, including 22 patients with gastric cancer, 31 patients with liver cancer, and 19 patients with pancreatic cancer; (2) After three-stage treatment, the effect was not obvious. In the case of no medication, the patient's VAS score is> 7 points, which is refractory pain; (3) the patient is difficult to tolerate traditional treatment; (4) the patient's survival time is more than 3 months; (5) No coagulopathy.
Exclusion criteria
Exclusion criteria: (1) patients with abnormal blood coagulation function; (2) patients with hepatic and renal insufficiency; (3) patients with cardiopulmonary failure; (4) patients with poorly controlled diabetes; (5) patients with surgical site infection; (6) occurrence of puncture site Patients with bone metastases. Randomly divided into a control group and an observation group with 36 patients in each group. There was no statistical difference between the two groups in gender, age, height, weight, body mass index and course of disease (P>0.05), which was comparable.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| VAS score; | — |
Secondary
| Measure | Time frame |
|---|---|
| QOL score; | — |
Contacts
Public ContactHe Meiyi
Foshan Chancheng Central Hospital
Outcome results
None listed